Carregant...
Elevations in Serum and Urinary Calcium with Parathyroid Hormone (1–84) with and without Alendronate for Osteoporosis
CONTEXT: The effect of PTH therapy on serum and urinary calcium levels and the risk of hypercalcemia or hypercalciuria has not been formally evaluated. OBJECTIVE: The objective was to examine changes in serum and urinary calcium associated with PTH(1–84) therapy in the PaTH trial and the extent to w...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3746103/ https://ncbi.nlm.nih.gov/pubmed/17164314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2006-1788 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|